Egyptian Society of Cardiology national advisory statement revisiting antiplatelet therapy: insights from E. S. C. 2025 hot-line trials. (PubMed, Egypt Heart J) - Jul 22, 2026 - "The Egyptian Society of Cardiology supports a more individualized, risk-based approach to antiplatelet therapy, emphasizing ischemic-bleeding balance, stent technology, revascularization completeness, and national resource considerations. Recommendations should be interpreted cautiously given the preliminary nature of some ESC 2025 data."
Journal • Review • Cardiovascular
|
|
Basem Zareef; Gamela Nasr; Haitham Soliman; Hamza Kabil; Islam Shawky; Khaled Shokry; Magdy Abd Elhameed; Mohamad Abd Elghany; Mohamad Zahran; Moustafa Mokarrab; Sameh Shaheen; Yasser Abd Elhady
|